Spectral launches rapid West Nile test in U.S.

Spectral Diagnostics has announced the conclusion of an agreement with Fisher Healthcare, a division of Thermo Fisher Scientific Inc., for the distribution of its RapidWN West Nile Virus Test in the United States.

Product shipments are expected to begin this month. Distribution channels for the RapidWN are now in place in the United States and in Canada.

The Center for Disease Control (CDC) has already reported six human cases of West Nile infection in three states as of June 12, 2007, and many states have confirmed the presence of the virus in mosquitoes or avian carriers. The peak incidence of infection typically occurs in August or September of each year.

"We are very pleased to have reached an agreement with Fisher for the distribution of our RapidWN," stated Mr. Robert Verhagen, Vice President of Business Development for Spectral. "Fisher's large and experienced sales force and its extensive geographic coverage provides a significant opportunity for entry of our product into the U.S. market", added Mr. Verhagen.

http://www.thermofisher.com and http://www.spectraldx.com.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, April 30). Spectral launches rapid West Nile test in U.S.. News-Medical. Retrieved on June 24, 2024 from https://www.news-medical.net/news/2007/07/04/27145.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Spectral launches rapid West Nile test in U.S.". News-Medical. 24 June 2024. <https://www.news-medical.net/news/2007/07/04/27145.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Spectral launches rapid West Nile test in U.S.". News-Medical. https://www.news-medical.net/news/2007/07/04/27145.aspx. (accessed June 24, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Spectral launches rapid West Nile test in U.S.. News-Medical, viewed 24 June 2024, https://www.news-medical.net/news/2007/07/04/27145.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New developments at Evosep to make clinical proteomics 100x more robust and 10x faster